Slide 1

Slide 2

Arrhythmias in Children: Assessment and Management Robert H. Pass, MD Director, Pediatric Cardiac Electrophysiology Montefiore Medical Center Albert Einstein College of Medicine

Slide 3

Pediatric Arrhythmia Management Bradycardia (Boring) vs. Tachycardias (Exciting) Disorders of Automaticity Disorders of Reentry

Slide 4

Pediatric Arrhythmia Management Normal Cardiac Conduction System Electrical Anatomic Substrate

Slide 5

Bradyarrhythmias Sinus Node Dysfunction: Rare in patients with structurally normal hearts Commonly seen following palliative congenital heart surgery: Acutely: AV Canal Repairs Sinus Venosus ASD repair Chronically: Mustard/Senning Repair of DTGA Fontan Palliation of Single Ventricular hearts

Slide 6

Bradyarrhythmias Mustard Procedure for D-Transposition of the Great Arteries

Slide 7

Bradyarrhythmias 75% of all DTGA patients undergoing Mustard at Columbia not in sinus rhythm at follow-up

Slide 8

Bradyarrhthmias Conduction Block ________ ______________ _________ _____________________________

Slide 9

Bradyarrhythmias Causes of Block: Infectious: Viral myocarditisDiptheria Lyme DiseaseEndocarditis Chagas Disease Inflammatory: Rheumatoid arthritisGuillain-Barre Trauma: Cardiac SurgeryBlunt chest trauma Radiation therapy Neurodegenerative: Myotonic dystrophyMuscular dystrophy Kearns-Sayre syndrome Infiltrative disorders: Tuberous SclerosisLymphoma AmyloidosisSarcoid Pharmacologic: Tricyclic antidepressantsAntiarrhythmic agents Digoxin Clonidine

Slide 10

Bradyarrhythmias Clinical Examples 7 year old with history of severe cold symptoms, lethargy, dyspnea and echocardiogram demonstrated severe ventricular dysfunction

Slide 11

Bradyarrhythmias Clinical Examples 8 year old referred to cardiology for evaluation of heart murmur

Slide 12

Bradyarrhythmias Treatment: - Treat underlying problem - If postoperative CHB or due to irreversible cause, pacemaker implantation

Slide 13

Bradyarrhythmias 9 Months old30 Months old Transvenous Pacemaker in Infant Loop technique ( from Spotnitz et al. Annals of Thoracic Surgery, 1991 )

Slide 14

Tachyarrhythmias Disorders of Automaticity VS. Disorders of Reentry

Slide 15

Tachyarrhythmias - Automatic Common characteristics of automatic arrhythmias include: - heat up / cool down - No abrupt onset or offset - Cannot be DC cardioverted - Very catecholamine sensitive

Slide 16

Tachyarrhythmias - Automatic Clinical Examples of Automatic Tachyarrhythmias: - Sinus tachycardia - Ectopic atrial tachycardia (EAT) - Junctional Ectopic Tachycardia (JET) - Some types of VT

Slide 17

Tachyarrhythmias Disorders of automaticity: Whatever is fastest in the heart wins In automatic arrhythmias, an area of myocardium with calcium channel cells fires at a rate that is faster than the sinus node and therefore controls the rhythm

Slide 18

Tachyarrhythmias - Automatic Clinical Example: 14 year old girl seen by pediatrician who heard irregular heart beat and obtained ECG; recent history of fainting without palpitations; Echocardiogram demonstrated severely depressed function

Slide 19

Tachyarrhythmias - Automatic EAT Ectopic Atrial Tachycardia Atrial ectopy from a single area of atrial myocardium other than sinus node Commonly results in ventricular dysfunction

Slide 20

Tachyarrhythmias - Automatic Clinical Example 5 mo s/p Tetralogy of Fallot repair postoperative hour 4 JET !!!!!!!

Slide 21

Tachyarrhythmias - Automatic Clinical Example: 15 year old with history of VT noncompliant with medication ER 1999

Slide 22

Tachyarrhythmias - Reentry Reentry - represents 90% of SVT in pediatric populations 3 Major Requirements: 1.2 pathways connected proximally and distally 2.Unidirectional block in one pathway 3.A zone of slow conduction

Slide 23

Tachyarrhythmias - Reentry Reentry General Characteristics: 1.Rhythm can be initiated and terminated with appropriately timed premature beats. 2.Abrupt onset and termination. 3.Successful termination (at least temporarily) with DC cardioversion

Slide 24

Tachyarrhythmias - Reentry Reentry Clinical examples of reentry include: -Accessory pathway (bypass tract) mediated tachycardia (e.g. WPW) -AV nodal reentry (AVNRT) -Atrial Flutter -Some ventricular tachycardias

Slide 25

Tachyarrhythmias - Reentry Accessory pathway tachycardia is most common etiology of tachycardia in children More common in males Typical route is from atria to ventricles via AV node and retrograde via accessory pathway Orthodromic Reentrant Tachycardia (ORT)

Slide 26

Tachyarrhythmias - Reentry Clinical example : 15 year old boy with history of Ebsteins anomaly and intermittent palpitations TachycardiaSinus Rhythm

Slide 27

Tachyarrhythmias - Reentry Peak age for occurrence of SVT/ORT is first 2 months of age 40% of first episodes occur this early in life Frequency decreases over first year of life 2/3 of infants no longer have clinical tachycardia at age 1 year and 1/3 have no evidence of accessory pathway conduction at one year by formal transesophageal testing

Slide 28

Tachyarrhythmias - Reentry Other peaks for tachycardia recurrence are 5-8 years and 10-15 years ~ 40% of patients with tachycardia as young infants will recur some time in life Reasons for this finding unclear

Slide 29

Tachyarrhythmias - Reentry WPW Paradigm of ORT First described in 1930 Short PR interval, bundle branch block on resting surface ECG and intermittent tachycardia Presence of delta wave ventricular preexcitation Risk of sudden death ~ 1.5/1000 pt. years

Slide 30

Tachyarrhythmias - Reentry Clinical example: 15 year old boy with insignificant past medical history seen in ER with palpitations and dizziness

Slide 31

Tachyarrythmias - Reentry Acute therapy was administered :

Slide 32

Tachyarrhythmias - Reentry ECG s/p DC Cardioversion Wolff Parkinson White Syndrome!

Slide 33

Tachyarrhythmias - WPW Mechanism of arrhythmia is preexcited atrial fibrillation Most common cause of sudden death in WPW

Slide 34

Tachyarrhythmias - WPW WPW Key points: 1.Risk of death is not from SVT/ORT but instead from rapidly conducted A fib (rare in infants). 2.Digoxin/Verapamil are contraindicated in older patients. 3.Parent education about identifying tachycardia critical.

Slide 35

Tachyarrhythmias - Reentry 16 year old with palpitations and dizziness 10 years s/p Fontan palliation for tricuspid atresia

Slide 36

Tachyarrhythmias - Reentry Intraatrial Reentrant Tachycardia (IART): -Common problem affecting 12.5-26% of patients with repaired/palliated CHD at intermediate and long-term follow-up -Particular problem among Fontan patients

Slide 37

Tachyarrhythmias - Reentry IART is virtually universal following Fontan (from Fishberger et al. JTCVS, 1997)

Slide 38

Tachyarrhythmias - Reentry Typical IART reentrant loop due to scarring in postoperative children

Slide 39

Tachyarrhythmias Summary of Mechanisms Level of HeartAutomaticityReentry SA NodeSinus tachycardia SA node reentry Atrial muscleEAT/MATAflutter/Afib AV NodeJETAVNRT AV reciprocatingNAWPW/ Concealed AP VentriclesVT/VFVT

Slide 40

Tachyarrhythmias - Treatment Chronic/Definitive therapy: Drug therapy in general, for most forms of SVT, drugs are effective Most commonly used agents: Digoxin Sotalol Procainamide Amiodarone Betablockers Flecainide Verapamil

Slide 41

Tachyarrhythmias Drug Therapy Acute therapy: IV adenosine causes transient AV nodal blockade Particularly useful for AV reciprocating tachycardias such as ORT or AVNRT (2 most common SVTs in children) IV verapamil also causes AV nodal blockade Not as commonly used due to potent negative inotropy also shown to be associated with cardiovascular collapse in infants

Slide 42

Tachyarrhythmias Drug Therapy Chronic Therapy: (Infancy) Digoxin Useful antiarrhythmic agent in infants Causes AV nodal slowing and reduces atrial ectopy Dosing from 8-14 mcg/kg/day divided bid Beta Blockers Useful alternative antiarrhythmic agent in infants Causes AV nodal slowing and reduces atrial ectopy Commonly used agent is Inderal Associated with low blood glucose levels D sticks must be monitored initially

Slide 43

Arrhythmias Drug Therapy Chronic Therapy Children and Adolescents: Beta blockade effective about 60-75% Low side effect profile Calcium channel blockers similar efficacy Low side effect profile (e.g. Verapamil) Digoxin not as effective in older patients as in infancy and thus not typically used in this age range

Slide 44

Arrhythmias Drug Therapy Chronic Therapy When the SIMPLE STUFF doesnt work: Sotalol Class III agent Potent beta blocker High incidence of proarrhythmia (~ 10%) Significantly more effective than simple agents Flecainide Class Ib agent Very effective ? High incidence of proarrhythmia (CAST study)

Slide 45

Arrhythmias Drug Therapy Amiodarone Class III agent (all 4 Vaughn Williams classification effects) Very effective agent Very long half life (~ 45 days) Low incidence of proarrhythmia High side effect profile PulmonaryLiverThyroidSkin EyeGI tract

Slide 46

Tachyarrhythmias - Therapy Drugs are not a free ride - Side effects (cardiac and non-cardiac) - Proarrhythmia - Not always efficacious - Compliance -? Lifelong usage - For WPW, may not reduce risk of sudden death

Slide 47

Tachyarrhythmias - Therapy Drug therapy for IART stinks -% freedom from recurrence of IART on various antiarrhythmic agents in patients s/p CHD surgery from Weindling et al. Unpublished abstract

Slide 48

Tachyarrhythmias - Therapy Radiofrequency Catheter Ablation (RFCA) Advantages: Potentially Definitive therapy Drug use often not required following procedure

Slide 49

Tachyarrhythmias - Therapy RFCA technical considerations Minimum of 4-5 catheters 2-3 cardiologists 1 nurse/1 CV tech Computerized on-line analysis Fluoroscopy Programmable stimulator

Slide 50

Tachyarrhythmias - Therapy Simplified example of successful ablation of left sided EAT focus in 5 year old

Slide 51

Slide 52

Tachyarrhythmias - Therapy DiagnosisSuccess (%) WPW94 Concealed AP99 PJRT95 EAT100 Mahaim100 AVNRT83 Totals90 RFCA Success Rates are quite high ! (Boston Childrens Data J Peds 1997) Data from Childrens Hospital at Montefiore for past 3 years overall success rate ~ 94%

Slide 53

Tachyarrhythmias - Therapy Risks associated with RFCA: Normal cath risks: bleeding, stroke, infection Serious complications (death, ventricular dysfunction, CVA, cardiac perforation) Occurred 1.2% of time in Tanel, Boston Childrens Study (1997)

Slide 54

Tachyarrhythmias - Therapy Angiogram of Fontan GIGANTIC RA so much ground to cover

Slide 55

Tachyarrhythmias - Therapy Data for standard RFCA of IART have been generally poor using standard techniques ~ 50% arrhythmia free at 2 years follow-up In light of these findings, interest in newer mapping techniques are growing

Slide 56

Tachyarrhythmias - Therapy Carto Biosense Electroanatomical Mapping System Newer Mapping Strategies

Slide 57

Tachyarrhythmias New Mapping Strategies Electroanatomical Mapping Non Contact Endocardial Solutions 9 French Balloon Catheter

Slide 58

Tachyarrhythmias Newer Therapies Newer Chilli catheters allowing larger and deeper radiofrequency lesions for IART in Fontan patients

Slide 59

Cryoablation Smaller reversible lesions

Slide 60

Tachyarrhythmias New Directions Refining of newer mapping strategies for better understanding of scar anatomy and its relationship to IART Newer surgical approaches to congenital surgery to reduce rates of IART or to treat it (cryosurgery) New catheter design to lower cath-related risks of RFCA (e.g. Cryocatheters) Use of low fluoroscopy protocols and 3 D electroanatomical mapping techniques to reduce exposure to ionizing radiation